CYP1A1 and metabolic dysfunction-associated steatotic liver disease: One study of CYP1A1(−/−) mice demonstrated that elevated expression of Cyp1a1 protects against NAFLD development, while dysregulation of the Cyp1a1 gene is reportedly involved in the transport and metabolism of lipids [28,29].